Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$4000.0.

  • Tonix Pharmaceuticals Holding's Exchange Rate Effect rose 7647.06% to -$4000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7000.0, marking a year-over-year increase of 12333.33%. This contributed to the annual value of $4000.0 for FY2024, which is 10615.38% up from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Exchange Rate Effect stood at -$4000.0 for Q3 2025, which was up 7647.06% from -$4000.0 recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Exchange Rate Effect high stood at $24000.0 for Q4 2024, and its period low was -$43000.0 during Q1 2023.
  • In the last 3 years, Tonix Pharmaceuticals Holding's Exchange Rate Effect had a median value of -$6500.0 in 2024 and averaged -$7800.0.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 34000.0% in 2024, then tumbled by 50000.0% in 2025.
  • Tonix Pharmaceuticals Holding's Exchange Rate Effect (Quarter) stood at -$10000.0 in 2023, then surged by 340.0% to $24000.0 in 2024, then crashed by 116.67% to -$4000.0 in 2025.
  • Its last three reported values are -$4000.0 in Q3 2025, -$4000.0 for Q2 2025, and -$9000.0 during Q1 2025.